JPMorgan Chase & Co’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.44M Buy
435,972
+137,956
+46% +$457K ﹤0.01% 3530
2025
Q1
$864K Buy
298,016
+222,516
+295% +$645K ﹤0.01% 3737
2024
Q4
$269K Buy
75,500
+30,467
+68% +$108K ﹤0.01% 4415
2024
Q3
$224K Buy
45,033
+13,199
+41% +$65.7K ﹤0.01% 4422
2024
Q2
$82.8K Sell
31,834
-70,585
-69% -$184K ﹤0.01% 4697
2024
Q1
$436K Buy
102,419
+51,363
+101% +$219K ﹤0.01% 4038
2023
Q4
$103K Buy
51,056
+50,818
+21,352% +$103K ﹤0.01% 4754
2023
Q3
$364 Sell
238
-1,070
-82% -$1.64K ﹤0.01% 5807
2023
Q2
$2.16K Buy
1,308
+1,123
+607% +$1.85K ﹤0.01% 5416
2023
Q1
$0 Hold
185
﹤0.01% 5783
2022
Q4
$0 Sell
185
-2,262
-92% ﹤0.01% 5554
2022
Q3
$3K Buy
2,447
+716
+41% +$878 ﹤0.01% 5263
2022
Q2
$1K Sell
1,731
-164,624
-99% -$95.1K ﹤0.01% 5465
2022
Q1
$434K Buy
166,355
+23,987
+17% +$62.6K ﹤0.01% 4077
2021
Q4
$554K Buy
142,368
+23,903
+20% +$93K ﹤0.01% 4001
2021
Q3
$517K Sell
118,465
-6,946
-6% -$30.3K ﹤0.01% 3938
2021
Q2
$497K Buy
125,411
+88,342
+238% +$350K ﹤0.01% 3998
2021
Q1
$193K Sell
37,069
-1,794
-5% -$9.34K ﹤0.01% 4465
2020
Q4
$208K Buy
38,863
+25,347
+188% +$136K ﹤0.01% 4133
2020
Q3
$60K Buy
13,516
+4,446
+49% +$19.7K ﹤0.01% 4238
2020
Q2
$44K Sell
9,070
-404,892
-98% -$1.96M ﹤0.01% 4247
2020
Q1
$907K Buy
413,962
+95,381
+30% +$209K ﹤0.01% 2997
2019
Q4
$1.85M Buy
318,581
+206,778
+185% +$1.2M ﹤0.01% 2739
2019
Q3
$356K Buy
111,803
+89,042
+391% +$284K ﹤0.01% 3486
2019
Q2
$93K Buy
22,761
+20,014
+729% +$81.8K ﹤0.01% 4048
2019
Q1
$19K Buy
2,747
+1,412
+106% +$9.77K ﹤0.01% 4514
2018
Q4
$8K Buy
1,335
+125
+10% +$749 ﹤0.01% 4637
2018
Q3
$21K Buy
+1,210
New +$21K ﹤0.01% 4561